Study on patent layout strategy of AstraZeneca's omeprazole
YAN Hua
DENG Sheng-ju
LIU Wen-xia
Abstract:Omeprazole is the first proton pump inhibitor on market and has brought huge profits to the original research company AstraZeneca.With the arrival of the patent cliff of Losec(R),it has triggered a fierce competition of imitation innovation in the global generic drugs field.AstraZeneca used good patent layout strategy to extend its market exclusivity period of brand drug omeprazole for additional 18 years.Through analyzing AstraZeneca's patent layout strategy,the article is expected to provide useful reference for medical innovators to protect their innovative research and medical innovation results.
Keywords:omeprazoleLosec(R)Nexiumpatent layoutintellectual property
Publication Date:2017-01-01
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:7( 1601-1607 )
Chinese Journal of New Drugs

Chinese Journal of New Drugs

PKUISTIC
ISSN:1003-3734
Year, Vol.(Issue):2017,26(14)